ACLARIS THERAPEUTICS INC. - COMMON STOCK
4.4100
01-5月-26 16:45:00
15 分の遅延
株式
+0.0700
+1.61%
本日の幅
4.2600 - 4.4600
ISIN
N/A
ソース
NASDAQ
-
Aclaris Therapeutics Appoints Jesse Hall, M.D. as Chief Medical Officer
29 4 2025 07:00:32 提供 Nasdaq GlobeNewswire
-
Aclaris Therapeutics to Participate in Two March Healthcare Conferences
04 3 2025 07:00:05 提供 Nasdaq GlobeNewswire
-
27 2 2025 06:59:55 提供 Nasdaq GlobeNewswire
-
12 2 2025 06:50:01 提供 Nasdaq GlobeNewswire
-
Aclaris Therapeutics Announces Formation of New Scientific Advisory Board
30 1 2025 16:01:21 提供 Nasdaq GlobeNewswire
-
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
06 1 2025 16:30:00 提供 Nasdaq GlobeNewswire
-
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
03 12 2024 16:30:00 提供 Nasdaq GlobeNewswire
-
Aclaris Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference
26 11 2024 16:30:00 提供 Nasdaq GlobeNewswire
-
Aclaris Therapeutics Announces $80 Million Private Placement
18 11 2024 08:10:41 提供 Nasdaq GlobeNewswire
-
18 11 2024 08:10:04 提供 Nasdaq GlobeNewswire
-
Aclaris Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
06 11 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Aclaris Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference
10 9 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Aclaris Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
07 8 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
16 7 2024 16:01:43 提供 Nasdaq GlobeNewswire
-
Aclaris Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
06 6 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Aclaris Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
07 5 2024 16:01:00 提供 Nasdaq GlobeNewswire
-
30 4 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
27 2 2024 07:00:00 提供 Nasdaq GlobeNewswire